Clinical monitoring of hirudin and direct thrombin inhibitors

Seminars in Thrombosis and Hemostasis

Volumn 27, Issue 5, 2001, Pages 537-541

  Nowak, G ^a  

^a NONE   (Germany)

Author keywords

APTT; Ecarin clotting time; Hirudin; Thromboembolism

Indexed keywords

CHROMOGENIC SUBSTRATE; ECARIN; HEPARIN; HIRUDIN; THROMBIN INHIBITOR;

ANTICOAGULATION; ARTICLE; BLOOD CLOTTING TIME; CONCENTRATION RESPONSE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DOSE RESPONSE; DRUG DETERMINATION; DRUG MONITORING; DRUG OVERDOSE; ECARIN CLOTTING TIME; HUMAN; LONG TERM CARE; NORMAL VALUE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; SIDE EFFECT; THROMBIN TIME; THROMBOEMBOLISM;

ANTITHROMBINS; BLOOD COAGULATION TESTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG MONITORING; ENDOPEPTIDASES; HIRUDIN THERAPY; HIRUDINS; HUMANS; THROMBIN;

EID: 0034782040     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-17964     Document Type: Article

References (9)

1. Assay of hirudin in plasma using a chromogenic thrombin substrate
2. Development of a chromogenic substrate assay for the determination of hirudin in plasma
3. Anticoagulation with r-hirudin in regular haemodialysis with heparin-induced thrombocytopenia (HIT II)
4. PEG-hirudin and acetylsalicylic acid show a strong interaction on bleeding time
5. Recombinant hirudin as an anticoagulant in open-heart surgery: A case report
6. Hirudin as an anticoagulant in cardiopulmonary bypass
7. Quantitative determination of hirudin in blood and body fluids
8. Effects of hirudin on activated partial thromboplastin time determined with ten different reagents